Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-312023-04-01The principal activity of the LLP during the year was that of a pharmacy. On 1 February 2021, 50% ofMember's equity capital was acquired by Day Lewis plc, a parent company of Community Pharmacies (UK) Ltd.falsetrue0true0false OC375502 2023-04-01 2024-03-31 OC375502 2022-04-01 2023-03-31 OC375502 2024-03-31 OC375502 2023-03-31 OC375502 c:CurrentFinancialInstruments 2024-03-31 OC375502 c:CurrentFinancialInstruments 2023-03-31 OC375502 d:EntityNoLongerTradingButTradedInPast 2023-04-01 2024-03-31 OC375502 d:FRS102 2023-04-01 2024-03-31 OC375502 d:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 OC375502 d:FullAccounts 2023-04-01 2024-03-31 OC375502 d:LimitedLiabilityPartnershipLLP 2023-04-01 2024-03-31 OC375502 d:PartnerLLP1 2023-04-01 2024-03-31 OC375502 d:PartnerLLP2 2023-04-01 2024-03-31 OC375502 c:OtherCapitalInstrumentsClassifiedAsEquity 2024-03-31 OC375502 c:OtherCapitalInstrumentsClassifiedAsEquity 2023-03-31 OC375502 c:FurtherSpecificReserve2ComponentTotalEquity 2024-03-31 OC375502 c:FurtherSpecificReserve2ComponentTotalEquity 2023-03-31 OC375502 e:PoundSterling 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure

Registered number: OC375502









NAILSEA HEALTHCARE LLP







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

 
NAILSEA HEALTHCARE LLP
 

INFORMATION




Designated Members

Community Pharmacies (UK) Limited
Day Lewis Plc

LLP registered number

OC375502

Registered office

2 Peterwood WayCroydonSurreyCR0 4UQ


 
NAILSEA HEALTHCARE LLP
 

CONTENTS



Page
Members' Report
1
Statement of Comprehensive Income
2
Statement of Financial Position
3
Reconciliation of Members' Interests
4
Notes to the Financial Statements
5 - 7


 
NAILSEA HEALTHCARE LLP
 
  
MEMBERS' REPORT
FOR THE YEAR ENDED 31 MARCH 2024

The Members present their annual report together with the financial statements of Nailsea Healthcare LLP ("the LLP") for the year ended 31 March 2024
 

Principal activities
 
 
The principal activity of the LLP continued to be that of a dormant LLP.
 
 
Designated Members
 
 
The Designated Members who held office during the year and up to the date of signature of the financial statements were as follows:
Community Pharmacies (UK) Limited
Day Lewis Plc
 

 
Members' capital and interests
 
 
Each Member's subscription to the capital of the LLP is determined in accordance with the terms of the LLP Agreement.
 
 
Details of changes in Members' capital in the year ended 31 March 2023 are set out in the Reconciliation of Members' Interests.
 
 
Members are remunerated from the profits of the LLP and are required to make their own provision for tax, pensions and other benefits. Profits are allocated and divided between Members after finalisation of the financial statements. Members may draw a proportion of their profit share monthly during the year in which it is made, with the balance of profits being distributed after the year end, subject to the cash requirements of the business.
 

This report was approved by the Members and signed on their behalf by: 






................................................
Community Pharmacies (UK) Limited 
Designated Member

Date: 5 September 2024
Page 1

 
NAILSEA HEALTHCARE LLP
 
 
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2024

The LLP has not traded during the year or the preceding financial year. During these periods, the LLP received no income and incurred no expenditure and therefore made neither profit or loss.


The notes on pages 5 to 7 form part of these financial statements.

Page 2

 
NAILSEA HEALTHCARE LLP
REGISTERED NUMBER: OC375502

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2024

2024
2023
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 3 
873,539
873,539

Total assets less current liabilities
  
 
 
873,539
 
 
873,539

  

Net assets
  
873,539
873,539


Represented by:
  

Loans and other debts due to members within one year
  

Members' other interests
  

Members' capital classified as equity
  
2
2

Other reserves classified as equity

  

873,537
873,537

  
 
873,539
 
873,539

  
873,539
873,539


Total members' interests
  

Members' other interests
  
873,539
873,539

  
873,539
873,539


The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small LLPs regime.

The entity was entitled to exemption from audit under section 480 of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008.

The Members acknowledge their responsibilities for complying with the requirements of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008, with respect to accounting records and the preparation of financial statements.

The financial statements were approved and authorised for issue by the Members and were signed on their behalf by: 



................................................
Community Pharmacies (UK) Limited
Designated Member
Date: 5 September 2024

The notes on pages 5 to 7 form part of these financial statements.

Page 3

 
NAILSEA HEALTHCARE LLP
 

RECONCILIATION OF MEMBERS' INTERESTS
FOR THE YEAR ENDED 31 MARCH 2024





EQUITY
Members' other interests
Members' capital (classified as equity)
Other reserves
Total

£
£
£

Balance at 1 April 2022 
2
873,537
873,539

Profit for the year available for discretionary division among Members
 
-
-
-

Members' interests after profit for the year
2
873,537
873,539

Other movements
 
-
-
-

Balance at 31 March 2023
2
873,537
873,539

Profit for the year available for discretionary division among members
 
-
-
-

Members' interests after profit for the year
2
873,537
873,539

Other movements
 
-
-
-

Balance at 31 March 2024 
2
873,537
873,539

The notes on pages 5 to 7 form part of these financial statements.

There are no existing restrictions or limitations which impact the ability of the Members of the LLP to reduce the amount of Members' other interests.

Page 4

 
NAILSEA HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

Nailsea Healthcare LLP is a limited liability partnership incorporated in England and Wales. The registered office is 2 Peterwood Way, Croydon, Surrey, United Kingdom, CR0 4UQ.
The limited liability partnerships principal activities and nature of its operations are disclosed in the Members' Report.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006 and the requirements of the Statement of Recommended Practice "Accounting by Limited Liability Partnerships".

The financial statements are prepared in sterling, which is the functional currency of the limited liability partnership. Monetary amounts in these financial statements are rounded to the nearest £.

 
2.2

Going concern

As the Members do not intend to acquire a replacement trade, the Members have not prepared the financial statements on a going concern basis.

Page 5

 
NAILSEA HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

  
2.3

Members' participation rights

Members' participation rights are the rights of a Member against the LLP that arise under the Members' agreement (for example, in respect of amounts subscribed or otherwise contributed, remuneration and profits).
Members' participation rights in the earnings or assets of the LLP are analysed between those that are, from the LLP's perspective, either a financial liability or equity, in accordance with section 22 of FRS 102. A Member's participation rights including amounts subscribed or otherwise contributed by members, for example Members' capital, are classed as liabilities unless the LLP has an unconditional right to refuse payment to Members, in which case they are classified as equity.
All amounts due to Members that are classified as liabilities are presented within 'Loans and other debts due to Members' and, where such an amount relates to current year profits, they are recognised within ‘Members' remuneration charged as an expense’ in arriving at the relevant year’s result. Unallocated amounts that are classified as equity are shown within ‘Members' other interests’. Amounts recoverable from Members are presented as debtors and shown as amounts due from Members within Members’ interests.
Where there exists an asset and liability component in respect of an individual Member’s participation rights, they are presented on a gross basis unless the LLP has both a legally enforceable right to set off the recognised amounts, and it intends either to settle on a net basis or to settle and realise these amounts simultaneously, in which case they are presented net.
Whilst the Members’ agreement does not differentiate between profits and losses for profit sharing purposes, it does stipulate that the LLP cannot demand additional contributions from Members, and as a result the LLP does not have an unconditional right to demand payment from Members for losses. Therefore, they are not recognised as a recoverable asset and so remain within equity as other reserves.
Other amounts applied to Members, for example remuneration paid under an employment contract and interest on capital balances, are treated in the same way as all other divisions of profits, as described above, according to whether the LLP has, in each case, an unconditional right to refuse payment. Amounts payable to Members under employment contracts and unavoidable interest on Members capital are charged to “Members remuneration charged as an expense” in the relevant year.


3.


Debtors

2024
2023
£
£


Amounts owed by group undertakings
873,539
873,539

873,539
873,539


Page 6

 
NAILSEA HEALTHCARE LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

4.


Related party transactions

The entity has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.


5.


Controlling party

The LLP is jointly controlled by Community Pharmacies (UK) Ltd and a parent company Day Lewis plc, a company registered in England and Wales. It prepares group accounts which are available at Day Lewis House, 2 Peterwood Way, Croydon, Surrey CR0 4UQ.
The ultimate parent company is Day Lewis Holdings Limited, a company registered in Cyprus and controlled by the executors of the KCTP Will Trust.
Copies of the ultimate parent and of its group financial statements are not publicly available.

Page 7